{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T13:17:12Z","timestamp":1679231832509},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Counsel of Technological and Scientific Development, CNPq","award":["564778\/2010-9"],"award-info":[{"award-number":["564778\/2010-9"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40744-016-0026-2","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T10:00:19Z","timestamp":1454061619000},"page":"143-154","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil"],"prefix":"10.1007","volume":"3","author":[{"given":"Marina Amaral de \u00c1vila","family":"de Machado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra Maciel","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Maria","family":"Kakehasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco de Assis","family":"Acurcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379\u201390.","journal-title":"Lancet"},{"issue":"6","key":"26_CR2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/14737167.2014.957679","volume":"14","author":"K Kotsis","year":"2014","unstructured":"Kotsis K, Voulgari PV, Drosos AA, et al. Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review. Expert Rev Pharmacoecon Outcomes Res. 2014;14(6):857\u201372.","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"issue":"6","key":"26_CR3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2011","unstructured":"Braun J, van den Berg R, Baraliakos X, et al. 2010 Update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896\u2013904.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"26_CR4","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00296-013-2772-6","volume":"33","author":"MA Machado","year":"2013","unstructured":"Machado MA, Barbosa MM, Almeida AM, et al. Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis. Rheumatol Int. 2013;33(9):2199\u2013213.","journal-title":"Rheumatol Int"},{"issue":"12","key":"26_CR5","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3899\/jrheum.150389","volume":"42","author":"AV Heinonen","year":"2015","unstructured":"Heinonen AV, Aaltonen KJ, Joensuu JT, L\u00e4hteenm\u00e4ki JP, Pertovaara MI, Romu MK, et al. Effectiveness and drug survival of TNF inhibitors in the treatment of ankylosing spondylitis: a prospective cohort study. J Rheumatol. 2015;42(12):2339\u201346.","journal-title":"J Rheumatol"},{"issue":"3","key":"26_CR6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/rheumatology\/kep422","volume":"49","author":"PA Lord","year":"2010","unstructured":"Lord PA, Farragher TM, Lunt M, et al. Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register. Rheumatology. 2010;49(3):563\u201370.","journal-title":"Rheumatology"},{"issue":"2","key":"26_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0482-50042011000200005","volume":"51","author":"DC Titton","year":"2011","unstructured":"Titton DC, Silveira IG, Louzada-Junior P, et al. Brazilian biologic registry: Biobada Brasil implementation process and preliminary results. Rev Bras Reumatol. 2011;51(2):152\u201360.","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"26_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rbr.2013.06.003","volume":"54","author":"CL Kohem","year":"2014","unstructured":"Kohem CL, Bortoluzzo AB, Gon\u00e7alves CR. Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides. Rev Bras Reumatol. 2014;54(1):33\u20137.","journal-title":"Rev Bras Reumatol."},{"issue":"9779","key":"26_CR9","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(11)60054-8","volume":"377","author":"J Paim","year":"2011","unstructured":"Paim J, Travassos C, Almeida C, et al. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377(9779):1778\u201397.","journal-title":"Lancet"},{"key":"26_CR10","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria n\u00ba 640, de 24 de julho de 2014. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Espondilite Ancilosante; 2014. http:\/\/portalsaude.saude.gov.br\/images\/pdf\/2014\/julho\/25\/pcdt-espondilite-ancilosante-2014.pdf . Accessed 22 Dec, 2014."},{"key":"26_CR11","first-page":"813","volume":"17","author":"MB Ferraz","year":"1990","unstructured":"Ferraz MB, Oliveira LM, Araujo PMP, et al. Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol. 1990;17:813\u20137.","journal-title":"J Rheumatol"},{"issue":"8","key":"26_CR12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s10067-006-0479-8","volume":"26","author":"SK Shinjo","year":"2007","unstructured":"Shinjo SK, Gon\u00e7alves R, Kowalski S, Gon\u00e7alves CR. Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation. Clin Rheumatol. 2007;26(8):1254\u20138.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"26_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.vhri.2013.01.009","volume":"2","author":"MV Andrade","year":"2013","unstructured":"Andrade MV, Noronha K, Kind P, et al. Societal preferences for EQ-5D health states from a Brazilian population survey. Value Health Reg Issues. 2013;2(3):405\u201312.","journal-title":"Value Health Reg Issues."},{"key":"26_CR14","volume-title":"EQ-5D a measure of health-related quality of life developed by the EuroQol group: user guide","author":"Euroqol Group","year":"2000","unstructured":"Euroqol Group. EQ-5D a measure of health-related quality of life developed by the EuroQol group: user guide. 7th ed. Rotterdam: EuroQol Group; 2000.","edition":"7"},{"issue":"11","key":"26_CR15","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ard.2009.124446","volume":"69","author":"B Glintborg","year":"2010","unstructured":"Glintborg B, Ostergaard M, Krogh NS, et al. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8\u00a0years\u2019 surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis. 2010;69(11):2002\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"26_CR16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00296-011-1797-y","volume":"32","author":"A Saeed","year":"2012","unstructured":"Saeed A, Khan M, Elmamoun M, et al. Ankylosing spondylitis in Ireland: patient access and response to TNF-\u03b1 blockers. Rheumatol Int. 2012;32(5):1305\u20139.","journal-title":"Rheumatol Int"},{"issue":"8","key":"26_CR17","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1002\/art.21209","volume":"52","author":"MS Heiberg","year":"2005","unstructured":"Heiberg MS, Nordv\u00e5g BY, Mikkelsen K, et al. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis Rheum. 2005;52(8):2506\u201312.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"26_CR18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10067-011-1890-3","volume":"31","author":"HM Carvalho de","year":"2012","unstructured":"de Carvalho HM, Bortoluzzo AB, Gon\u00e7alves CR, et al. Brazilian Registry on Spondyloarthritis. Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin Rheumatol. 2012;31(4):687\u201395.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"26_CR19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4081\/reumatismo.2014.756","volume":"66","author":"FM Perrotta","year":"2014","unstructured":"Perrotta FM, Addimanda O, Ramonda R, et al. Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNF\u03b1 drugs. Reumatismo. 2014;66(3):208\u201314.","journal-title":"Reumatismo."},{"issue":"6","key":"26_CR20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1590\/S0482-50042010000600005","volume":"50","author":"VF Azevedo","year":"2010","unstructured":"Azevedo VF, Paiva ED, Felippe LRH, Moreira RA. Occurrence of fibromyalgia in patients with ankylosing spondylitis. Rev Bras Reumatol. 2010;50(6):646\u201350.","journal-title":"Rev Bras Reumatol"},{"issue":"8","key":"26_CR21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","volume":"34","author":"F Salaffi","year":"2014","unstructured":"Salaffi F, De Angelis R, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int. 2014;34(8):1103\u201310.","journal-title":"Rheumatol Int"},{"issue":"6","key":"26_CR22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","volume":"22","author":"A Maghraoui El","year":"2011","unstructured":"El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22(6):554\u201360.","journal-title":"Eur J Intern Med."},{"issue":"5","key":"26_CR23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10067-015-2929-7","volume":"34","author":"BP Faf\u00e1","year":"2015","unstructured":"Faf\u00e1 BP, Louzada-Junior P, Titton DC, et al. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL. Clin Rheumatol. 2015;34(5):921\u20137.","journal-title":"Clin Rheumatol"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.23333","volume":"59","author":"MS Heiberg","year":"2008","unstructured":"Heiberg MS, Koldingsnes W, Mikkelsen K, et al. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study. Arthritis Rheum. 2008;59:234\u201340.","journal-title":"Arthritis Rheum"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar1941","volume":"8","author":"L Carmona","year":"2006","unstructured":"Carmona L, G\u00f3mez-Reino JJ. Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER. Arthritis Res Ther. 2006;8:R72.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"26_CR26","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2014-205490","volume":"73","author":"E Lie","year":"2014","unstructured":"Lie E, Fagerli KM, Mikkelsen K, et al. First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002\u20132011: data from the NOR-DMARD register. Ann Rheum Dis. 2014;73(10):1905\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"26_CR27","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.clinthera.2013.09.015","volume":"35","author":"I Navarro-Mill\u00e1n","year":"2013","unstructured":"Navarro-Mill\u00e1n I, Sattui SE, Curtis JR. Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis. Clin Ther. 2013;35(11):1850\u201361.","journal-title":"Clin Ther"},{"issue":"12","key":"26_CR28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.5414\/CP201707","volume":"50","author":"V Nell-Duxneuner","year":"2012","unstructured":"Nell-Duxneuner V, Schroeder Y, Reichardt B, Bucsics A. The use of TNF-inhibitors in ankylosing spondylitis in Austria from 2007 to 2009\u2014a retrospective analysis. Int J Clin Pharmacol Ther. 2012;50(12):867\u201372.","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-016-0026-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-016-0026-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T03:41:07Z","timestamp":1567568467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40744-016-0026-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s40744-016-0026-2","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}